HASPIN and neoplasm: We furtherimproved LJ4827’s anticancer effect by examining potentialsynergistic partners for cytotoxicity alongside HASPIN inhibition.Rather than genome-wide CRISPR screening, we performed an in silicoanalysis in which synergistic LJ4827 partners were screened basedon LUAD patients’ tumor transcriptomes.